Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-040298
Filing Date
2023-03-31
Accepted
2023-03-31 17:21:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2310905d1_424b5.htm 424B5 300515
2 EX-FILING FEES tm2310905d1_ex-filingfees.htm EX-FILING FEES 1258
3 GRAPHIC tm2310905d1_424b5img001.jpg GRAPHIC 4912
4 GRAPHIC tm2310905d1_424b5img01.jpg GRAPHIC 3804
  Complete submission text file 0001104659-23-040298.txt   315153
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252625 | Film No.: 23789249
SIC: 2834 Pharmaceutical Preparations